| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |